Quotient

Baudax Bio

SoFi Technologies

Use these penny stocks risk management tips for trading The post Penny Stocks Risk Management: 3 Tips and Tricks  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Penny Stocks Risk Management: 3 Tips and Tricks

Troika Media Group

Use these techniques for day trading penny stocks The post Penny Stocks Day Trading: 3 Techniques to Use in 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Penny Stocks Day Trading: 3 Techniques to Use in 2023

JERSEY, Channel Islands, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the "Company") today announced that it has given formal notice to the Nasdaq Stock Market LLC ("Nasdaq") of its intention to voluntarily delist its ordinary shares from the Nasdaq Global Market. In order to implement the delisting, the Company intends to file a Form 25 with the Securities and Exchange Commission (the "SEC") on or about December 27, 2022. The delisting of the Company's ordinary shares will take effect no earlier than ten days after the date of that Form 25 filing. The Company expects that as a result of this voluntary delisting, the last trading day of its ordinary shares on the Nasdaq Global Market will be on or about January 6, 2023. The Company expects that in connection with the transactions referred to below, it will seek to suspend its reporting obligations under the Securities Exchange Act of 1934. The Company does not intend to apply to list its ordinary shares on any other stock exchange or for quotation of its ordinary shares in any quotation medium.

Quotient Limited Announces Intent to Voluntary Delist from the Nasdaq Global Market

Quotient Technology

The digital marketing specialist refinanced a massive convertible debt load and gained market share in a difficult market environment.

Why Quotient Technology Stock Soared More Than 25% Higher Today

JERSEY, Channel Islands, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the "Company"), a commercial-stage diagnostics company, today announced that a reverse split of its ordinary shares, nil par value ("Ordinary Shares"), at a ratio of 1-for-40 became effective following close of trading on the Nasdaq Global Market today. The Company's Ordinary Shares will begin trading on a split-adjusted basis when the market opens on November 3, 2022 under the existing trading symbol, "QTNT."

Quotient Limited Announces Reverse Stock Split Effective Today

JERSEY, Channel Islands, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the "Company"), a commercial-stage diagnostics company, today announced that it will effect a one-for-40 reverse stock split ("Reverse Stock Split") of its ordinary shares, nil par value ("Ordinary Shares") that will become effective on November 2, 2022 at 5:01 p.m. Eastern Time, after the close of trading on The Nasdaq Global Market ("Nasdaq"). The Company's Ordinary Shares are expected to begin trading on a split-adjusted basis when the market opens on November 3, 2022 on the Nasdaq under the existing symbol “QTNT.”

Quotient Limited Announces Intent to Effect Reverse Stock Split

Sannova Appoints Jason Apter as CEO and Stephen Unger as CFO

JERSEY, Channel Islands, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient), headquartered in Eysins, Switzerland, today announced it was selected by the World Economic Forum to join their New Champions Community.

Quotient Limited Selected to Join the World Economic Forum New Champions Community

• The National Screening Laboratory of Sanquin Blood Supply Foundation joins MosaiQ Innovator's Circle

Quotient Limited Expands MosaiQ Innovator's Circle to Empower Patient Care and Laboratory Efficiencies

Quotient Limited (NASDAQ:QTNT ) Q1 2023 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Ali Kiboro - Chief Financial Officer Manuel Mendez - Chief Executive Officer Conference Call Participants Josh Jennings - Cowen Brandon Couillard - Jefferies Matt Sykes - Goldman Sachs Operator Greetings and welcome to the Quotient Limited First Quarter Fiscal Year 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Quotient Limited (QTNT) CEO Manuel Mendez on Q1 2023 Results - Earnings Call Transcript

Quotient (QTNT) delivered earnings and revenue surprises of -32.14% and 6.23%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Quotient (QTNT) Reports Q1 Loss, Lags Revenue Estimates

Quotient (QTNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Quotient (QTNT) to Report a Decline in Earnings: What to Look Out for

Partnership aims to expand the Transfusion Transmissible Infections, other Infectious Diseases, and clinical diagnostics assay menu on Quotient's multimodality, multiplexed MosaiQ solution Partnership aims to expand the Transfusion Transmissible Infections, other Infectious Diseases, and clinical diagnostics assay menu on Quotient's multimodality, multiplexed MosaiQ solution

Quotient Limited and InfYnity Biomarkers Announce Partnership to Expand MosaiQ Infectious Disease Menu

ComSovereign Holding

Dermata Therapeutics

Penny stocks to watch under $1 The post Hot Penny Stocks To Buy? 3 Under $1 To Watch Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Hot Penny Stocks To Buy? 3 Under $1 To Watch Now

JERSEY, Channel Islands, July 01, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the scheduled grant of equity awards to Mr. Steven Zuiderwijk, who has been appointed as the Chief Strategy & Business Development Officer of the Company effective July 1, 2022.

Quotient Limited Announces Equity Awards

JERSEY, Channel Islands, June 29, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the "Company"), a commercial-stage diagnostics company, announced the closing of its previously announced underwritten public offering of 32,458,336 ordinary shares and pre-funded warrants to purchase 34,208,331 ordinary share for aggregate gross proceeds of approximately $20.0 million. The net proceeds to the Company from this offering were approximately $18.5 million, after deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company.

Quotient Limited Announces Closing of Underwritten Offering of Ordinary Shares and Pre-Funded Warrants

Quotient Limited (NASDAQ:QTNT ) Q4 2022 Earnings Conference Call June 24, 2022 8:00 AM ET Company Participants Ali Kiboro - CFO Manuel Mendez - CEO Conference Call Participants Brandon Couillard - Jefferies Josh Jennings - Cowen Matt Sykes - Goldman Sachs Operator Greetings. Welcome to Quotient Limited Fourth Quarter and Full Year Fiscal Year 2022 Financial Results Conference Call.

Quotient Limited (QTNT) CEO Manuel Mendez on Q4 2022 Results - Earnings Call Transcript

Quotient (QTNT) delivered earnings and revenue surprises of 26.47% and 23.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Quotient (QTNT) Reports Q4 Loss, Tops Revenue Estimates

JERSEY, Channel Islands, June 24, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the Company), a commercial-stage diagnostics company, today announced the pricing of an underwritten public offering of 66,666,667 ordinary shares and ordinary share equivalents for aggregate gross proceeds of $20.0 million. The aggregate net proceeds to the Company from this offering are expected to be approximately $18.5 million, after deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company. All of the securities sold in the offering were offered by the Company. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 10,000,000 of its ordinary shares. The offering is expected to close on June 28th, 2022, subject to customary closing conditions.

Quotient Limited Announces Pricing of Underwritten Offering

JERSEY, Channel Islands, June 24, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today reported its fourth quarter fiscal 2022 key financial results and provided an update on recent business developments and key upcoming milestones. “I am deeply proud of the tremendous progress we have achieved at Quotient during my first year as CEO,” said Manuel O. Mendez, Chief Executive Officer of Quotient. “We received European CE mark approval of the MosaiQ Extended IH microarray in March, and we are announcing a financing with key equity and debt restructuring to strengthen our balance sheet and provide the necessary capital to improve our liquidity runway and advance our commercial and clinical execution strategy. We have a talented and experienced management team to lead us through this period of exciting growth and shareholder value creation for our company.”

Quotient Limited Provides Fourth Quarter Fiscal 2022 Results and Business Update

Improved debt terms reduces $93 million principal amortization payments over next 36 months Improved debt terms reduces $93 million principal amortization payments over next 36 months

Quotient Limited Announces Proposed Amendments to Senior Secured Notes

JERSEY, Channel Islands, June 23, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the Company), a commercial-stage diagnostics company, today announced the Company intends to commence an underwritten public offering of $20 million of its ordinary shares and, to certain investors in lieu of ordinary shares, pre-funded warrants. All of the securities to be sold in the offering will be offered by the Company. In addition, the Company intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the ordinary shares sold in the public offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.

Quotient Limited Announces Proposed Underwritten Offering

Quotient Ltd (NASDAQ: QTNT) shares are trading higher Wednesday after the company issued guidance above analyst estimates. Quotient announced that it has rescheduled its financial results to June 24.

Why Quotient Stock Is Soaring Today

JERSEY, Channel Islands, June 21, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced that it is rescheduling the release of its financial results for the fourth quarter and full year 2022 ended March 31, 2022. The Company will release these financial results and host a conference call before market open on Friday, June 24, 2022.

Quotient Limited Reschedules Fourth Quarter and Full Year 2022 Financial Results Announcement to Friday, June 24th and Provides a Preview of Financials

JERSEY, Channel Islands, June 17, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal fourth quarter and full year ended March 31, 2022 will be released before market open on Wednesday, June 22, 2022.

News for Quotient Stock (QTNT)